Clinical Trials Directory

Trials / Unknown

UnknownNCT02612363

Early Goal Directed Sedation on Microcirculation in Septic Shock

The Effect of Early Goal Directed Sedation on Microcirculation in Septic Shock Patients With Mechanical Ventilation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators will conduct a prospective, single-center, randomized, double-blinded, controlled study to investigate the effect of early goal directed sedation on microcirculation in early septic shock patients.

Detailed description

Recent studies suggest that early goal directed sedation might improve the outcome of critically ill patients. The investigators will conduct a prospective, single-center, randomized, double-blinded, controlled study to investigate the effect of early goal directed sedation on microcirculation in early septic shock patients with relative stable hemodynamics.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidine for sedationDexmedetomidine or control drug for sedation * Analgesia * Propofol at lowest dosage. * Dose range: 0.1- 0.7 u/kg/hour * Target RASS score of -2 to +1 * Supplemental other sedatives at lowest effective dose

Timeline

Start date
2015-11-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-11-23
Last updated
2016-04-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02612363. Inclusion in this directory is not an endorsement.

Early Goal Directed Sedation on Microcirculation in Septic Shock (NCT02612363) · Clinical Trials Directory